RIA
TXMD icon

Realta Investment Advisors’s TherapeuticsMD TXMD Stock Holding History

Realta Investment Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed -$13K – 1308
2019
Q4 		$13K Buy
100
+60
+150% +$8.63K ﹤0.01% 1069
2019
Q3 		$7K Hold
40
– – ﹤0.01% 1238
2019
Q2 		$5K Buy
+40
New +$7.17K ﹤0.01% 1389

Other funds holding TXMD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Realta Investment Advisors's TXMD Position: Q1 2020 in Review

Realta Investment Advisors sold out of TherapeuticsMD (TXMD) in Q1 2020, closing a stake of 100 shares — an estimated $13K sold.

Realta Investment Advisors first reported a position in TXMD in Q2 2019 and held it in 3 quarters. The position peaked at $13K in Q4 2019. 143 funds tracked by Wall St. Rank hold TXMD as of Q1 2020.

  • Realta Investment Advisors reported no remaining TherapeuticsMD position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 100 TherapeuticsMD shares in Q1 2020, an estimated $13K.
  • Realta Investment Advisors first reported a position in TherapeuticsMD in Q2 2019 and held it in 3 quarters.
  • Realta Investment Advisors's TherapeuticsMD position peaked at $13K in Q4 2019.
  • 143 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.